Effect of Dupilumab on Aspirin Intolerance

Clinical trial NCT04442256 · UNKNOWN

Trial details

NCT number: NCT04442256
Sponsor: Medical University of Vienna
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

AERD - Aspirin Exacerbated Respiratory Disease

Start date: 2020-06-01
Primary completion: 2022-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.